Norbert W. Bischofberger, EVP, R&D and CSO at GILEAD SCIENCES INC (GILD), sold 70,000 shares at $103.26 ($7.2M) on 2015-02-17, disclosed to the SEC on 2015-02-19.
Scheduled sale ($7.2M) by EVP, R&D and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $102.65 | 29,114 | $3.0M | 41.4% |
| 2 | $103.26 | 40,886 | $4.2M | 58.6% |
| Total | $103.01 avg | 70,000 | $7.2M | 100% |
| Filing → |
| KRON | BUY | 2023-11-17 | $2.7M | — | Filing → |
| KRON | BUY | 2022-05-19 | $3.4M | — | Filing → |
| KRON | BUY | 2021-12-08 | $347K | — | Filing → |